Skip to main content
. Author manuscript; available in PMC: 2021 May 1.
Published in final edited form as: Personal Disord. 2019 Dec 9;11(3):230–236. doi: 10.1037/per0000385

Table 2.

Bivariate correlations between variables.

Variable 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19

1 Age -- .17* −.20** −.09 −.14 −.24** .04 −.29** −.35** −.28** −.04 −.28** −.14 −.19* −.14 .05 .09 −.25** −.05
2 Sex -- .19** .16* .07 .08 .14 −.09 −.12 −.06 .14 −.06 .18* .13 .16* .22** .03 −.07 .20**
3 Borderline Features -- .37** .27** .26** .27** .29** .15* .15* .22** .23** .31** .27** .29* .32** .19** .19** .31**
4 Alcohol Coping -- .79** .75** .50** .26** .21** .22** .25** .22** .30** .34** .33** .32** .71** .18* .25**
5 Alcohol Enhancement -- .80** .42** .23** .34** .26** .21** .20* .27** .38** .31** .26** .57** .21** .20**
6 Alcohol Social -- .42** .22** .25** .28** .20** .21** .28** .35** .32** .22** .48** .17* .19**
7 Alcohol Conformity -- .25** .11 .17* .53** .29** .21** .21** .26** .22** .21** .12 .18*
8 Cannabis Coping -- .74** .83** .43** .71** .29** .34** .34** .20** .14 .71** .24**
9 Cannabis Enhancement -- .80** .30** .60** .21** .33** .28** .15* .07 .61** .22**
10 Cannabis Social -- .41** .68** .26** .31** .34** .12 .10 .67** .23**
11 Cannabis Conformity -- .47** .34** .30** .31** .23** .10 .29** .32**
12 Cannabis Expansion -- .28** .27** .30** .16* .05 .50** .24**
13 Rx Opioid Coping -- .85** .87** .51** .07 .20** .80**
14 Rx Opioid Enhancement -- .86** .53** .15* .25** .73**
15 Rx Opioid Social -- .45** .13 .24** .70**
16 Rx Opioid Pain -- .22** .16* .51**
17 Alcohol Use Disorder -- .18* .07
18 Cannabis Use Disorder -- .18*
19 Rx Opioid Use Disorder --

Note. Rx = prescription. Substance use disorder variables are symptomotology count and not actual diagnosis of the disorder.

*

p < .05;

**

p < .01.